| Ms Lacinda Glass, RPH | |
|
600 Boll Weevil Cir, Enterprise, AL 36330-2715 | |
| (334) 347-2199 | |
| (334) 347-3095 |
| Full Name | Ms Lacinda Glass |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 600 Boll Weevil Cir, Enterprise, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952830192 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 12790 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Lacinda Glass, RPH 106 Dee Rd, Opp, AL 36467-2549 Ph: (334) 379-6135 | Ms Lacinda Glass, RPH 600 Boll Weevil Cir, Enterprise, AL 36330-2715 Ph: (334) 347-2199 |
News Archive
Michigan State University has launched the nation's first comprehensive research and training program designed to address product counterfeiting- which the FBI has called "the crime of the 21st century."
The Household & Commercial Products Association released the following statement today about the importance of air fresheners after a newly published review article revealed several negative psychological, physical, social, and economic effects associated with indoor malodors, such as stale indoor air and bad smells.
Argos Therapeutics today announced two oral presentations detailing data on its soluble CD83 (sCD83) protein program at the 2010 American Transplant Congress, held May 1-5 in San Diego. The data, which were produced by Argos in collaboration with scientists from the University of Western Ontario, demonstrate that sCD83 is capable of inducing immune system tolerance to transplant grafts and suppressing an anti-donor antibody response, via a multi-faceted mechanism-of-action that impacts B and T cells, as well as dendritic cells.
Depomed, Inc., a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration issued a complete response letter to the New Drug Application for SEFELSA, Depomed's investigational, oral, twice daily formulation of gabapentin to treat moderate to severe vasomotor symptoms due to menopause.
The decision earlier this month by CMS not to extend a moratorium on approval of new specialty hospitals likely will prompt a "building boomlet" of the facilities, the Wall Street Journal reports.
› Verified 8 days ago
Joseph Paul Russell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 204 E Brunson St, Enterprise, AL 36330 Phone: 334-347-6865 Fax: 334-393-0679 | |
Christine Anne Mcculley, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 N Edwards St, Enterprise, AL 36330 Phone: 334-347-1202 | |
Dr. Michele L Garrett Iv, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 900 Fort Rucker Blvd, Enterprise, AL 36330 Phone: 334-393-1348 | |
Mr. Gregory Larkin Goodson, NRPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 612 N Main St, Suite A, Enterprise, AL 36330 Phone: 334-393-0086 Fax: 334-393-0206 | |
Gladys Theiler, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 900 Rucker Blvd, Enterprise, AL 36330 Phone: 334-393-1348 Fax: 393-393-1386 | |
Cheryl Massey, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 903 Rucker Blvd, Enterprise, AL 36330 Phone: 334-393-4440 Fax: 334-393-2449 | |
Natasha Lynn Rosekrans, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 850 Boll Weevil Cir, Enterprise, AL 36330 Phone: 334-389-3143 |